chr8-89784119-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003821.6(RIPK2):c.1009G>A(p.Val337Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000326 in 848,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003821.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPK2 | NM_003821.6 | c.1009G>A | p.Val337Ile | missense_variant | 8/11 | ENST00000220751.5 | NP_003812.1 | |
RIPK2 | NM_001375360.1 | c.598G>A | p.Val200Ile | missense_variant | 7/10 | NP_001362289.1 | ||
RIPK2 | XM_011517357.3 | c.496G>A | p.Val166Ile | missense_variant | 6/9 | XP_011515659.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPK2 | ENST00000220751.5 | c.1009G>A | p.Val337Ile | missense_variant | 8/11 | 1 | NM_003821.6 | ENSP00000220751 | P1 | |
RIPK2 | ENST00000522965.1 | c.*648G>A | 3_prime_UTR_variant, NMD_transcript_variant | 7/10 | 1 | ENSP00000429271 |
Frequencies
GnomAD3 genomes AF: 0.000346 AC: 38AN: 109956Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.000190 AC: 41AN: 215662Hom.: 0 AF XY: 0.000179 AC XY: 21AN XY: 117400
GnomAD4 exome AF: 0.000323 AC: 239AN: 738934Hom.: 0 Cov.: 20 AF XY: 0.000298 AC XY: 115AN XY: 386498
GnomAD4 genome AF: 0.000346 AC: 38AN: 109956Hom.: 0 Cov.: 26 AF XY: 0.000238 AC XY: 12AN XY: 50496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2023 | The c.1009G>A (p.V337I) alteration is located in exon 8 (coding exon 8) of the RIPK2 gene. This alteration results from a G to A substitution at nucleotide position 1009, causing the valine (V) at amino acid position 337 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at